Genus plc (LON:GNS – Get Free Report) insider Jorgen Kokke sold 50,236 shares of the stock in a transaction on Monday, September 14th. The shares were sold at an average price of GBX 2,151, for a total value of £1,080,576.36.
Genus Stock Up 0.2%
GNS stock traded up GBX 4 during trading on Wednesday, hitting GBX 2,154. 565,982 shares of the company’s stock were exchanged, compared to its average volume of 780,717. The stock has a market capitalization of £1.43 billion, a price-to-earnings ratio of 30.34, a PEG ratio of 2.87 and a beta of 0.90. The company has a current ratio of 2.22, a quick ratio of 1.08 and a debt-to-equity ratio of 14.02. Genus plc has a 52-week low of GBX 1,943 and a 52-week high of GBX 3,220. The business has a 50-day moving average price of GBX 2,219.71 and a two-hundred day moving average price of GBX 2,354.38.
Genus (LON:GNS – Get Free Report) last announced its earnings results on Thursday, September 10th. The company reported GBX 110.30 earnings per share (EPS) for the quarter. Genus had a return on equity of 44.90% and a net margin of 43.35%. As a group, equities research analysts expect that Genus plc will post 70.9644323 EPS for the current year.
Analysts Set New Price Targets
Read Our Latest Research Report on GNS
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Stories
- Five stocks we like better than Genus
- Movado’s Turnaround Gains Momentum
- Qualcomm’s Discount Could Vanish If Its AI Bet Pays Off
- Micron’s AI Memory Boom Could Send Shares 100% Higher
- Apple Stock Surges After Its Biggest Product Launch in Years—Can It Last?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
